CS-1103

· Clear Scientific, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for CS-1103, covering 2025-11-10 to 2026-03-27. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Safety, Tolerability, PK, and Efficacy Study of CS-1103 Following Fentanyl Challenge With Naloxone Blockade [Phase 2]

See pricing